Cheng Named Chief of CSR Review Group
The Center for Scientific Review has named Dr. Yuanna Cheng as chief of its surgical sciences, biomedical imaging and bioengineering (SBIB) integrated review group. She had been acting chief and previously served as scientific review officer for the clinical and integrative cardiovascular sciences study section and the electrical signaling, ion transport and arrhythmias study section.
“Since coming to CSR in 2011, Yuanna has demonstrated a keen ability to understand, communicate and implement policy to drive the highest quality of review,” said acting CSR director Dr. Noni Byrnes. “She is a member of the CSR’s best practices committee and has been a key resource for CSR leadership in the implementation of the new NIH clinical trials policies.” Byrnes also noted that Cheng is well-suited to lead this review group due to her broad clinical background along with her research experience in using advanced imaging modalities and her previous involvement in training the next generation of biomedical engineers.
Cheng will oversee six standing study sections and numerous special emphasis panels that review a broad range of NIH grant applications.
She received an M.D. at Tongji Medical University in China and a Ph.D. in physiology at the Medical College of Oita in Japan. This was followed by a postdoctoral fellowship in the division of cardiology at the University of Pittsburgh. She was then recruited to the Cleveland Clinic, where her research focused increasingly on translational aspects of cardiac electrophysiology.
Before joining CSR, Cheng was associate staff in the department of cardiovascular medicine and department of molecular cardiology at Cleveland Clinic as well as an adjunct associate professor in the department of biomedical engineering at Case Western Reserve University.